111, Inc. (YI)
The company now
111, Inc. is classed by the SEC under Retail-Drug Stores and Proprietary Stores (industry code 5912), based in Shanghai. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of CNY 13 billion and a loss of CNY 23 million (its filed statements).
From its filings and filed figures; the desk's account of it is not written yet.
Where the revenue comes from
fiscal 2025, as filedRevenue by product, fiscal 2025
| Product | Fiscal 2025 | Fiscal 2024 | Share of revenue |
|---|---|---|---|
| Drugs | CN¥11.65B | CN¥13.40B | 92.2% |
| Nutritional Supplements | CN¥435M | CN¥550M | 3.4% |
| Business to Consumer B2c Business | CN¥223M | CN¥261M | 1.8% |
| Medical Supplies and Devices | CN¥152M | CN¥144M | 1.2% |
| Service | CN¥85.4M | CN¥107M | 0.7% |
| Mp Service | CN¥56.7M | CN¥65.5M | under 1% |
| Service Other | CN¥28.6M | CN¥41.0M | under 1% |
As tagged in its annual report (Form 20-F, filed Apr 30, 2026 ↗), read from the SEC's financial statement data sets. The year before is the figure the record holds for the prior fiscal year.
The desk's written account of this company, its Past, Present and Future, is not on file yet.
How the company works
The desk has not read this company's annual report yet.
The record in brief
The desk has not written this company's report yet.